The Story Of Our Firm | En Français | En Español
 Home    Lawyers   Litigation   Contact Us   Verdicts   Search

Personal Injury Injuries Health Alerts Medical Devices

2008 Medical Device Advisories

in this section: Animas Insulin Pump Battery Caps | Viscosurgical Device | Integra NeuroSciences | Pediatric Arterial Cannulae | Stryker Cranial | ReliOn Insulin Syringes | Vibe Technologies/Nebion LLC | NexStent | Cochlear Implants


Bookmark This Page Print This Page Email This Page

Thoratec Corporation Issues Worldwide Medical Device Correction of HeartMate II® Left Ventricular Assist System

The FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company. This release involves the recall of Thoratec Corporation’s HeartMate II Left Ventricular Assist Systems (HM II LVAS).

FOR IMMEDIATE RELEASE -- PLEASANTON, CA -- October 24, 2008—Thoratec Corporation is initiating a worldwide medical device correction of all serial numbers of the HeartMate II Left Ventricular Assist Systems (HM II LVAS) having Catalogue No. 1355 or 102139, which have been distributed since the beginning of clinical studies in November 2003. Over time, wear and fatigue of the percutaneous lead connecting the HeartMate II LVAS blood pump with the System Controller may result in damage that could interrupt pump function, require reoperation to replace the pump and potentially result in serious injury or death. The estimated probability of the need for pump replacement due to percutaneous lead damage is 1.3% at 12 months, 6.5% at 24 months and 11.4% at 36 months.

Patients who are currently being supported by a HeartMate II LVAS should contact their doctors, who can assess the wear and fatigue of the percutaneous lead as well as provide proper instruction on management and care of the lead.

Thoratec is voluntarily issuing an Urgent Medical Device Correction notice after confirming 27 reports where wear and fatigue to the percutaneous lead necessitated pump replacement. These reports occurred over five years of clinical experience with 1,972 implants. All patients who have undergone a replacement of the HeartMate II pump survived the operation and were alive at least 30 days postoperatively. In five cases, pump replacement was not feasible and the patients expired.

The affected systems were distributed to 153 hospitals and distributors throughout the United States, Europe, Canada and other countries. The HM II LVAS can be identified by the catalogue number located on the label of the package.

Hospitals are being sent an Urgent Medical Device Correction letter identifying the probability and symptoms of the problem, and recommending that the pump be replaced as soon as possible if damage to the percutaneous lead is confirmed. Hospitals are also requested to review the instructions for care of the percutaneous lead with their ongoing HeartMate II LVAS patients. Hospitals with ongoing HeartMate II LVAS patients should contact Thoratec for further instructions if they do not receive the Medical Device Correction letter. The labeling for the HeartMate II LVAS will be revised with the updated risk information related to percutaneous lead damage. Copies of this press release may be found on Thoratec’s website, www.thoratec.com, under Investor Relations/Press Releases.

Clinicians and patients with questions may contact the company at 1-800-528-2577, or if calling from outside the USA, 1-925-847-8600 (7 days a week, 8-5 Pacific Time).

FDA has been informed of this action.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Online: www.fda.gov/medwatch/report.htm

Regular Mail: use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail to MedWatch 5600 Fishers Lane, Rockville, MD 20852-9787
Fax: 1-800-FDA-0178


see also:

Animas Insulin Pump Battery Caps Recall of Animas insulin pump models for problems with battery caps
Animas insulin pumps with defective battery caps subject of FDA recall

Viscosurgical Device Recall of Healon D Ophthalmic Viscosurgical Device (OVD) announced
Class 1 recall of Healon D Ophthalmic Viscosurgical Device by the FDA

2007 Medical Device Advisories Recall: Exacta Mix 2400 Operating Software System has Software Failure
Deadly defect allows extra ingredient to be added to IV in Exacta Mix

Name
Phone
Email
Do you have a legal question? Ask us!    strictly confidential
Your Question
  • MESOTHELIOMA
    • Mesothelioma Treatment
    • Mesothelioma Symptoms
    • Lung Cancer
    • Help for Veterans
    • Asbestos Exposure
    • Your Legal Options
    • Mesothelioma Lawyer
    • Asbestos Cancer
  • DEFECTIVE MEDICINES AND DEVICES
      Actos
      DePuy Hip
      Fosamax
    • Accutane
    • Avandia
    • Depakote
    • Gadolinium
    • Hydroxycut
    • Paxil Birth Defects
    • Qui Tam
    • Reglan
    • Shoulder Pain Pumps
    • Topamax
    • Pelvic Mesh
    • Yaz/Yasmin/Ocella
    • Zimmer Durom
    • Zimmer NexGen-CR Flex Porous Femoral component
    • Zimmer LPS-Flex
    • Zoloft Birth Defects
  • ENTERTAINMENT LAW
    • Intellectual Property
    • Creative Rights
    • Royalties
    • Licensing Fees
    • Breach of Contract
    • Fraud
  • ENVIRONMENTAL POLLUTION
    • Arsenic
    • Benzene
    • Chromium
    • Dioxins
    • Gulf Oil Spill
    • Landfill Odors
    • Lead Poisoning
    • Mercury Poisoning
    • Pesticides
    • Petroleum Spills
    • PCB
    • Property Damage
    • Radium
    • TCE
    • Water Contamination
    • Vapor Intrusion
  • ACCIDENTS
    • Auto Accident
    • Car Accident
    • Elevator Accident
    • Truck Accident
    • Workplace Accident
    • Pedestrian Knock-down
    • Bicyclist Collision
    • Motorcycle Collision
    • Single-Car Collision
    • Toyota Recall
    • Two-Car Collision
    • Multi-Car Collision
  • PERSONAL INJURY
    • Aviation
    • Back Injury
    • Birth Defects
    • Burn Injury
    • Brain Injury
    • Eye Injury
    • Life Insurance Law
    • Nursing Home Abuse
    • Spinal Cord Injury
    • Wrongful Death
    • Product Liability
    • Assault
    • Battery
    • Dog Bite
    • Stray Electricity
  • MEDICAL MALPRACTICE
    • New York Medical Malpractice
    • Anesthesia Complications
    • Birth Injury
    • Brachial Plexus Palsy
    • Cancer Misdiagnosis
    • Cerebral Palsy
    • Death
    • Erb’s Palsy
    • Failure to Diagnose
    • Foreign Object
    • Hospital Error
    • Hydrocephalus
    • Informed Consent
    • Medication Error
    • Pain and Suffering
    • Paraplegia
    • Podiatric Malpractice
    • Quadriplegia
    • Surgical Error
Name:
Phone:
Email:
Case Description:


$423 million settlement
MTBE suit involving the contamination of 153 public water systems nationally
$16.5 million verdict
Asbestos case involving exposure from dental tape
$1.4 million settlement
Accident involving woman struck down by ambulance
$1.5 million settlement
for 47-year-old construction worker who fell off elevated train tracks
$6 million settlement
Pediatric malpractice involving infant who suffered brain damage at birth
$53 million verdict
brake mechanic suffering from mesothelioma
$13.5 million verdict
one of the very first Vioxx trial cases
$15 million settlement
man wound up a paraplegic due to negligent hospital care
$37 million verdict
2 asbestos lung cancer plaintiffs
$47 million verdict
boilermaker who died from mesothelioma
$2.6 million settlement
ill-fitting prosthesis caused decubitus ulcers
$75 million verdict
historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s
$8 million settlement
obstetrical malpractice resulted in neurological deficits
$64.65 million award
4 asbestos plaintiffs
$17.5 million
consolidated trial of 5 mesothelioma victims
Ask a Free Question:
Were you injured?
check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases,

get the compensation to which they’re entitled and continue with their lives. In just over 25 years, we’ve collected more than $7 billion for plaintiffs.

Copyright © 2012 Weitz & Luxenberg, 700 Broadway, New York, NY 10003

Wi3 Prior results do not guarantee a similar outcome.
HOME | DISCLAIMER | SITE MAP | CONTACT US |NEWS CENTER | CAREERS